# Comparing HAI-90Y (SIR-spheres)+Chemotx LV5FU2 Versus Chemotx LV5FU2 Alone to Treat Colorectal Cancer

> **NCT01895257** · PHASE3 · UNKNOWN · sponsor: **Universiteit Antwerpen** · enrollment: 162 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DEVICE:** HAI-90Y radioembolization (SIR-spheres injection)
- **DRUG:** systemic chemotherapy LV5FU2

## Key facts

- **NCT ID:** NCT01895257
- **Lead sponsor:** Universiteit Antwerpen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2017-12
- **Final completion:** 2018-12
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2017-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01895257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01895257, "Comparing HAI-90Y (SIR-spheres)+Chemotx LV5FU2 Versus Chemotx LV5FU2 Alone to Treat Colorectal Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01895257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*